Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study

PURPOSE: In the randomized phase III trial, Gynecologic Oncology Group protocol 240, the incorporation of bevacizumab with chemotherapy significantly increased overall survival (OS) in women with advanced cervical cancer. A major objective of GOG-240 was to prospectively analyze previously identifie...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin Cancer Res
Main Authors: Tewari, Krishnansu S., Sill, Michael W., Monk, Bradley J., Penson, Richard T., Long, Harry J., Poveda, Andrés, Landrum, Lisa M., Leitao, Mario M., Brown, Jubilee, Reid, Thomas J.A., Michael, Helen E., Moore, David H.
格式: Artigo
語言:Inglês
出版: 2015
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896296/
https://ncbi.nlm.nih.gov/pubmed/26672085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-1346
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍